US 12280055
Combination therapies
granted A61KA61K31/502A61K31/5025
Quick answer
US patent 12280055 (Combination therapies) held by Mirati Therapeutics, Inc. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/502, A61K31/5025, A61K31/506, A61K31/519